Access to patient-level data from GlaxoSmithKline clinical trials.
Publication
, Journal Article
Nisen, P; Rockhold, F
Published in: N Engl J Med
August 1, 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
August 1, 2013
Volume
369
Issue
5
Start / End Page
475 / 478
Location
United States
Related Subject Headings
- Internet
- Information Dissemination
- Humans
- General & Internal Medicine
- Drug Industry
- Drug Evaluation
- Confidentiality
- Clinical Trials as Topic
- Access to Information
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Nisen, P., & Rockhold, F. (2013). Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med, 369(5), 475–478. https://doi.org/10.1056/NEJMsr1302541
Nisen, Perry, and Frank Rockhold. “Access to patient-level data from GlaxoSmithKline clinical trials.” N Engl J Med 369, no. 5 (August 1, 2013): 475–78. https://doi.org/10.1056/NEJMsr1302541.
Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med. 2013 Aug 1;369(5):475–8.
Nisen, Perry, and Frank Rockhold. “Access to patient-level data from GlaxoSmithKline clinical trials.” N Engl J Med, vol. 369, no. 5, Aug. 2013, pp. 475–78. Pubmed, doi:10.1056/NEJMsr1302541.
Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med. 2013 Aug 1;369(5):475–478.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
August 1, 2013
Volume
369
Issue
5
Start / End Page
475 / 478
Location
United States
Related Subject Headings
- Internet
- Information Dissemination
- Humans
- General & Internal Medicine
- Drug Industry
- Drug Evaluation
- Confidentiality
- Clinical Trials as Topic
- Access to Information
- 42 Health sciences